Improving outcomes with long-term “destination” therapy using left ventricular assist devices
- 30 June 2008
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 135 (6) , 1353-1361
- https://doi.org/10.1016/j.jtcvs.2006.09.124
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Long‐Term Destination Therapy With the HeartMate XVE Left Ventricular Assist Device: Improved Outcomes Since the REMATCH StudyCongestive Heart Failure, 2005
- Left ventricular assist devices as destination therapy: A new look at survivalThe Journal of Thoracic and Cardiovascular Surgery, 2005
- Infection in permanent circulatory support: Experience from the REMATCH trialThe Journal of Heart and Lung Transplantation, 2004
- Patient Selection for Left Ventricular Assist DevicesArtificial Organs, 2004
- Surgical management of patients in the REMATCH trialThe Annals of Thoracic Surgery, 2003
- Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart FailureNew England Journal of Medicine, 2001
- The REMATCH trial: rationale, design, and end pointsThe Annals of Thoracic Surgery, 1999
- Treatment of infected left ventricular assist device using antibiotic-impregnated beadsThe Annals of Thoracic Surgery, 1999
- Outpatient Left Ventricular Assist Device Support: A Destination Rather Than a BridgeThe Annals of Thoracic Surgery, 1996
- Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist deviceThe Annals of Thoracic Surgery, 1992